Results 21 to 30 of about 24,475 (136)

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia

HIV/AIDS: Research and Palliative Care, 2021
Abate Dargie Wubetu,1 Kokebie Kefelegn Asefa,2 Birhan Gebresillassie Gebregiorgis2 1Debre Berhan University, College of Health Science, Department of Psychiatry, Debre Berhan, Ethiopia; 2Debre Berhan University, College of Health Science, Department of ...
Wubetu AD, Asefa KK, Gebregiorgis BG
doaj  

Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon

The Pan African Medical Journal, 2019
INTRODUCTION: The introduction of highly active antiretroviral therapy (HAART) in the treatment of HIV infection has provided different good results: like long-term viral suppression, the decrease of opportunistic infections, and repair of the immune ...
Pepanze Jill, Mbunka Muhamed Awolu, Simo Gustave, Tayong Gladys, Samuel Nambile Cumber   +4 more
doaj   +1 more source

Ameliorative Potential of Resveratrol on Kidney Toxicities Following Adjuvant Treatment with Antiretroviral Drugs in Male Wistar Rats [PDF]

Archives of Razi Institute
Prolonged utilization of antiretroviral agents has been explicitly associated with nephrotoxicity, suggesting deterioration in renal function among patients receiving Highly Active Antiretroviral Therapy (HAART).
Oluwatosin Ogedengbe, Emuobonuvie Imoyin-Omene, Adeshina Adekeye, Basiru Ajiboye, Olusola Adeeyo   +4 more
doaj   +1 more source

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source

Features of the course and therapy of HIV infection in children at different stages of the disease

Журнал инфектологии, 2020
Purpose of the study. Analysis of clinical and laboratory features of the course of HIV infection and antiviral therapy in children at different stages of the disease.Materials and methods.
J. C. Hakizmana, E. B. Yastrebova, V. N. Timchenko, D. A. Gusev, O. V. Bulina   +4 more
doaj   +1 more source

Temporal shifts in antiretroviral therapy regimens and metabolic outcomes in people living with HIV: A systematic review and meta‐analysis

HIV Medicine, EarlyView.
Abstract Introduction Antiretroviral therapy (ART) for people living with HIV has led to dramatically reduced mortality and improved life expectancy. This achievement is accompanied by a higher risk for metabolic and other non‐communicable diseases. The role and contribution of various ART regimens to adverse metabolic outcomes are not fully understood.
Melani Ratih Mahanani, Myo Chit, Sophie Mohr, Elisenda Cama i Gibernau, Svetlana Hetjens, Volker Winkler, Hans‐Michael Steffen, Florian Neuhann   +7 more
wiley   +1 more source

Determining the prevalence of Human Immunodeficiency Virus-Associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population

The Pan African Medical Journal, 2012
BACKGROUND: HIV associated nephropathy (HIVAN) is the most common form of chronic kidney disease resulting directly from HIV infection. The true prevalence of HIVAN in the paediatric population of West Africa is unknown, largely due to lack of ...
Enobong Emmanuel Ikpeme, Udeme Ekpenyong Ekrikpo, Mkpouto Udeme Akpan, Samuel Itemobong Ekaidem   +3 more
doaj   +1 more source

Metabolic syndrome in human immunodeficiency virus positive patients

Indian Journal of Endocrinology and Metabolism, 2013
Aims and Objectives : To assess the prevalence of metabolic syndrome (MetS) in human immunodeficiency virus (HIV) positive patients. Prevalence of MetS was compared in patients who were not on highly active antiretroviral therapy (HAART) to patients who ...
Sarita Bajaj, Susheel Kumar Tyagi, Anudita Bhargava   +2 more
doaj   +1 more source

Study of association of urine albumin to creatinine ratio with endothelial dysfunction in HIV patients on HAART

Asian Journal of Medical Sciences, 2021
Background: In HIV (Human immunodeficiency virus) positive patients several factors have been proposed to explain the cardiovascular (CV) risk, which include pro-athero-thrombotic viral effect, infection-mediated immune dysfunction and possible effects ...
Sharana Basava Hoskera , Avinash Hanbe Rajanna , Nitish Ashok Gurav , Ashok ML   +3 more
doaj   +1 more source

Long‐Acting Cabotegravir/Rilpivirine Reduces Immune‐Activation and ‐Senescence in People With HIV With CMV Co‐Infection

Immunology, EarlyView.
This study investigates the impact of switching to long‐acting (LA) injectable cabotegravir and rilpivirine (CAB/RPV‐LA) on immune‐activation and ‐senescence in people with HIV (PWH). Thirty‐seven PWH switching to CAB/RPV‐LA and nine continuing oral ART were analysed over 72 weeks. LA therapy led to significant reductions in activation T and senescence
Mariasilvia Guardiani, Eeva Tortellini, Anna Carraro, Maria Antonella Zingaropoli, Lorenzo Ansaldo, Alessandra Grimaldi, Serena Vita, Federica Dominelli, Fabio Mengoni, Caterina Pasquazzi, Ombretta Turriziani, Maria Rosa Ciardi, Vincenzo Vullo, Claudio Maria Mastroianni, Raffaella Marocco, Cosmo Del Borgo, Miriam Lichtner   +16 more
wiley   +1 more source